Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Carac, Efudex, Fluorouracil

Carac, Efudex, Fluorouracil News Editors

News Widget

Display the Carac, Efudex, Fluorouracil news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Carac, Efudex, Fluorouracil News

News on Carac, Efudex, Fluorouracil (generic) continually updated from thousands of sources around the net.

Tuesday | BioMed Central

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or...

We investigated this combination as neoadjuvant therapy for locally advanced pancreatic cancer .

Comment?

Related Topix: Pancreatic Cancer, Health

Fri May 25, 2012

CiteULike

A randomized phase III study of radiotherapy alone or with...

A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.

Comment?

Related Topix: Medicine, Medication, Adrucil, Fluorouracil (generic), Pancreatic Cancer, Health, Oncology, Physics, Science

CiteULike

Therapy of locally unresectable pancreatic carcinoma: a randomized...

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose radiation alone, moderate dose radiation , and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group.

Comment?

Related Topix: Medicine, Medication, Adrucil, Fluorouracil (generic), Pancreatic Cancer, Health

Thu May 24, 2012

Gazette.net

Gaithersburg drug-maker signs deal for European market

Wellstat Therapeutics is selling to a London company certain rights, plus an option for marketing rights, for its experimental drug used as an antidote in cancer chemotherapy.

Comment?

Related Topix: Gaithersburg, MD, Marketing, Medicine, Medication, Adrucil, Fluorouracil (generic)

Thu Apr 26, 2012

Medical News

CytRx commences INNO-206 Phase 2 clinical trial for pancreatic cancer

CytRx Corporation , a biopharmaceutical company specializing in oncology , today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas who have progressed after receiving two prior therapies.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, CytRx, Healthcare Industry, Pancreatic Cancer, Health, Oncology, PDAs, Medication

Also on Topix